FEDERATED HERMES, INC. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 90 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.99 and the average weighting 1.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$845
+0.6%
1700.0%0.00%
Q1 2023$840
-100.0%
170
-99.9%
0.00%
-100.0%
Q4 2022$1,722,535
+172153.5%
273,853
+636767.4%
0.01%
Q3 2022$1,0000.0%430.0%0.00%
Q2 2022$1,000
-99.8%
43
-99.9%
0.00%
-100.0%
Q1 2022$535,000
+32.1%
58,693
+265.8%
0.00%0.0%
Q4 2020$405,000
-87.2%
16,044
-80.9%
0.00%
-85.7%
Q3 2020$3,171,000
-37.1%
84,088
-28.6%
0.01%
-41.7%
Q2 2020$5,040,000
-0.4%
117,707
-32.7%
0.01%
-7.7%
Q1 2019$5,059,000
+7.3%
175,0000.0%0.01%0.0%
Q4 2018$4,713,000175,0000.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders